Current through September 18, 2024
4.9.1
General
Requirements
Each clinical laboratory or station shall have clearly
established internal and external quality control programs to ensure high
standards of performance and reliability of test results. These programs shall
consider such factors as preventive maintenance, periodic inspection, testing
for proper operation of equipment and instruments as may be appropriate,
validation of methods, evaluation of reagents and volumetric equipment,
surveillance results, remedial action taken to correct deficiencies and such
other relevant factors as required in these rules and regulations and as may be
deemed necessary.
4.9.2
Procedural Manual
A. Each
clinical laboratory shall have available at all times in the immediate bench
area of personnel engaged in conducting clinical laboratory testing, a
procedure manual that includes a detailed compilation of all automated and
manual methods and procedures for all clinical tests that are performed by the
laboratory and for which it is licensed. Furthermore, such manual shall:
1. Contain information concerning preparation
and storage of reagents, control and calibration procedures and pertinent
literature references;
2. Describe
the laboratory's technical procedures for the collection, processing and
examination of specimens based on current standards of practice;
3. For those tests that are normally
performed on automated test equipment, provide for alternate methods or for
storage of the test specimens, in the event the automated equipment becomes
inoperable; and
4. Procedures shall
be approved, signed, and dated by the laboratory director. Procedures shall be
re-approved, signed and dated if the directorship of the laboratory changes.
Each change in a procedure shall be approved, signed, and dated by the current
director of the laboratory.
B. Each station shall have available at all
times a procedure manual that includes a detailed compilation of methods and
procedures for the collection, processing, and transmission of specimens
including preparation of patients, based on current practices.
4.9.3
Collection,
Identification and Examination of Specimens
A. No specimen shall be examined if
unsuitable for testing as a result of improper collection, improper
preservation, apparent spoilage, excessive time lapse between collection and
examination, or for such other reason(s) that would render findings of doubtful
validity.
B. Specimens shall be
examined only at the documented request of a licensed physician or other
authorized medical personnel, pursuant to statutory provisions of this
state.
C. Clinical laboratories in
state and out of state may receive reference specimens for examination provided
the reference laboratory is licensed in this state, pursuant to R.I. Gen. Laws
Chapter 23-16.2 and this Part.
D.
Whenever a clinical laboratory licensed by the state of Rhode Island isolates
any one of the specified microorganisms identified in the rules and regulations
pertaining to Reporting and Testing of Infectious, Environmental and
Occupational Diseases (Part 30-05-1 of this Title), the original culture or a
subculture shall be submitted to the Rhode Island Department of Health
Laboratory for confirmation, typing, or banking in accordance with the
aforementioned regulations.
1. All specimens
shall be accompanied by identifying data such as name of the patient, physician
or other authorized medical personnel, and laboratory.
E. A clinical laboratory collecting blood for
lead analysis and/or performing blood lead analyses shall do so in accordance
with the regulations of Reporting and Testing of Infectious, Environmental and
Occupational Diseases (Part 30-05-1 of this Title) and Lead Poisoning
Prevention (Part 50-15-3 of this Title).
4.9.4
Radiobioassay, Pathological, and
Cytological Examinations
A. A clinical
laboratory licensed in the category of radiobioassay shall comply with the
applicable rules and regulations for Radiation (Chapter 40 Subchapter 20 of
this Title).
B. Pathological
examination of specimens of excised tissue(s) shall be performed only by a
physician licensed in this state who is either qualified for certification, or
is certified in anatomic pathology by the American Board of
Pathology.
C. Cytological
examination of specimens shall be performed only under the supervision of a
physician licensed in this state who is either qualified for certification, or
is certified in anatomic pathology or cytopathology by the American Board of
Pathology.
4.9.5
Methodologies for Quality Control
A. Each clinical laboratory shall establish
an internal program of quality control covering each type of analysis performed
for the verification and assessment of accuracy, measurement of precision, and
detection of error. The factors that constitute the quality control provisions
shall be based on current acceptable standards of practice such as those
promulgated in the most current version of the rules and regulations of the
Department of Health and Human Services' "Clinical Laboratory Improvement
Amendments of 1988."
B. Each
clinical laboratory shall furthermore be required to participate in an external
proficiency testing program to assess the accuracy and reliability of testing
performance for each category and subcategory of clinical specialties for which
the laboratory is licensed.
1. Appropriate
proficiency testing programs shall be those approved by the U.S. Department of
Health and Human Service or such as those the Director may deem appropriate
based upon national standards.
2. A
determination of satisfactory performance on proficiency testing shall be made
by the licensing agency based on the passing score for each analyte as
established by the proficiency testing program.